Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-08-Speech-3-092"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20100908.5.3-092"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, I am not at all sure about the exemption for generic medicines. If we grant this, we will, in such cases, also have to grant exemption to all transit, otherwise we will encounter the problems that we have seen in recent years. You say that it will only apply to large-scale commercial cases. In that case, you could say that individuals
be exempt, rather than that they
be exempt from the rules, could you not?
I am also concerned about the digital environment when there is talk of technological barriers. In this regard, it is said that methods that can be used to circumvent technical protection measures should be regarded as unlawful if they have limited commercial use.
It could also be the case that these are disseminated entirely without financial interest, that someone has no financial interest at all, but instead wishes to support people’s use of technologies that could also be used as ‘circumvention technologies’. How do you view this?
I am also not at all happy about the fact that you are including here controversial aspects from Ipred and with regard to data storage. If we will want to change this after the evaluations, it is stupid to have established it here in writing."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples